Big Announcement Alert: Discoveries meet momentum. Right here.

Fitzsimon_menu

Find out what's happening on campus and across the industry.

Read Fitzsimons Innovation Community news, industry highlights, editorials, and innovation updates happening weekly on our campus.

European Medicines Agency (EMA) Validates Atara Biotherapeutics' Marketing Authorization Application
News | Nov 30, 2021

European Medicines Agency (EMA) Validates Atara Biotherapeutics' Marketing Authorization Application

Atara Biotherapeutics announced that the Marketing Authorization Application (MAA) for tabelecleucel (tab-cel®) has been fully validated by the European Medicines Agency (EMA).

Pathways Bioscience Seeks to Optimize Aging
News | Nov 30, 2021

Pathways Bioscience Seeks to Optimize Aging

Pathways Bioscience’s technology improves healthspan and overcomes health and wellness problems associated with aging.

Two CU Cancer Center Members Recognized as World Experts in Pancreatic Neoplasms
News | Nov 19, 2021

Two CU Cancer Center Members Recognized as World Experts in Pancreatic Neoplasms

Expertscape rankings recognize Richard Schulick, MD, and Marco Del Chiaro, MD, among the top 0.1% of scholars worldwide.

Taiga Initiates Phase 1/2 Clinical Study of TBX-2400 in Acute Myeloid Leukemia and Myelofibrosis in Croatia
News | Nov 10, 2021

Taiga Initiates Phase 1/2 Clinical Study of TBX-2400 in Acute Myeloid Leukemia and Myelofibrosis in Croatia

TBX-2400 is expected to improve engraftment and reconstitution of immune system for patients receiving Hematopoietic Stem Cell Transplants.